Chinese Practice Guideline for Therapeutic Drug Monitoring of Vancomycin: Recommendations External Review_Chinese Journal of Evidence-Based Medicine

Authors：

 CHENKen ^1,2 , WANGQi ^3,4 , CHENYao-long ^3,4 ,  ZHAISuo-di ¹

1. Pharmacy Department, Peking University Third Hospital, Beijing 100191, China;
2. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
4. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China;
1. Key Laboratory of Clinical Translational Research and Evidence-based Medicine of Gansu Province, Lanzhou 730000, China;

Corresponding author：

ZHAISuo-di, Email: zhaisuodi@163.com

Keywords：

Clinical practice guideline; Evidence-based guideline; External review; Recommendations

DOI：

10.7507/1672-2531.20150119

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective Chinese practice guideline for therapeutic drug monitoring of vancomycin is the first therapeutic drug monitoring guideline in the framework of GRADE in China. The guideline panels met a recommendation consensus in December 21^th, 2014 and finalized 14 recommendations. The aim of the current study was to assess the property of recommendations and revise them. Methods We commissioned an external review of recommendations by questionnaire. Physicians, clinical pharmacists and nurses above or equal to intermediate certificate were investigated for appreciations, clarity and feasibility of 14 recommendations as well as other suggestions about guideline. The guideline panels discussed the results and revised recommendations based on the result of external review. Results A total of 40 physicians, clinical pharmacist and nurses from 11 departments of 4 hospitals participated in the external review. The overall appreciation degree of recommendations was 70%, the overall clarity degree of recommendations was 88%, and the overall feasibility degree of recommendations was 70%. Among them, appreciation degree of 4 recommendations and feasibility degree of 5 recommendations were fewer than 50%. 165 subjective suggestions were received. After review of the results, the guideline panels reserved 6 recommendations while revised 8 (Deleted 4, combined 2 and improved 2). Conclusion Our external review is an exploration and attempt in the region of development of Chinese evidence-based practice guideline. More interest-related individuals are involved in the development of guideline. Clarity and feasibility of recommendations are ensured.

Citation： CHENKen, WANGQi, CHENYao-long, ZHAISuo-di. Chinese Practice Guideline for Therapeutic Drug Monitoring of Vancomycin: Recommendations External Review. Chinese Journal of Evidence-Based Medicine, 2015, 15(6): 719-722. doi: 10.7507/1672-2531.20150119 Copy

1.	Schunemann HJ,Wiercioch W,Etxeandia I,et al.Guidelines 2.0:systematic development of a comprehensive checklist for a successful guideline enterprise.CMAJ,2014,186(3):E123-142.
2.	Chen YL,Yao L,Xiao XJ,et al.Quality assessment of clinical guidelines in China:1993-2010.Chin Med J (Engl),2012,125(20):3660-3664.
3.	韦当,王小琴,吴琼芳,等.2011年中国临床实践指南质量评价.中国循证医学杂志,2013,13(6):760-763.
4.	李楠,姚亮,吴琼芳,等.2012~2013年中国大陆期刊发表临床实践指南质量评价.中国循证医学杂志,2015,15(3):259-263.
5.	Available at:http://www.tdmchina.org/portal.php?mod=view&aid=373.
6.	Available at:http://www.guidelines-registry.org.
7.	陈耀龙,陈恳,叶志康,等.中国万古霉素治疗药物监测指南的制定.中国循证医学杂志,2015,2015(2):236-239.
8.	The guidelines manual.London (UK):National Institute for Health and Clinical Excellence,2012.Available at:http://www.publications.nice.org.uk/the-guidelines-manual-pmg6.org.
9.	SIGN 50:a guideline developer's handbook.Edinburgh (UK):Scottish Intercollegiate Guidelines Network,2011.Available at:http://www.sign.ac.uk/guidelines/fulltext/50/.
10.	World Health Organization.WHO Handbook for guideline development-2nd ed.World Health Organization,2014.

1. Schunemann HJ,Wiercioch W,Etxeandia I,et al.Guidelines 2.0:systematic development of a comprehensive checklist for a successful guideline enterprise.CMAJ,2014,186(3):E123-142.
2. Chen YL,Yao L,Xiao XJ,et al.Quality assessment of clinical guidelines in China:1993-2010.Chin Med J (Engl),2012,125(20):3660-3664.
3. 韦当,王小琴,吴琼芳,等.2011年中国临床实践指南质量评价.中国循证医学杂志,2013,13(6):760-763.
4. 李楠,姚亮,吴琼芳,等.2012~2013年中国大陆期刊发表临床实践指南质量评价.中国循证医学杂志,2015,15(3):259-263.
5. Available at:http://www.tdmchina.org/portal.php?mod=view&aid=373.
6. Available at:http://www.guidelines-registry.org.
7. 陈耀龙,陈恳,叶志康,等.中国万古霉素治疗药物监测指南的制定.中国循证医学杂志,2015,2015(2):236-239.
8. The guidelines manual.London (UK):National Institute for Health and Clinical Excellence,2012.Available at:http://www.publications.nice.org.uk/the-guidelines-manual-pmg6.org.
9. SIGN 50:a guideline developer's handbook.Edinburgh (UK):Scottish Intercollegiate Guidelines Network,2011.Available at:http://www.sign.ac.uk/guidelines/fulltext/50/.
10. World Health Organization.WHO Handbook for guideline development-2nd ed.World Health Organization,2014.

Chinese Journal of Evidence-Based Medicine

Chinese Practice Guideline for Therapeutic Drug Monitoring of Vancomycin: Recommendations External Review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content